Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of CHF 205.21 billion. The enterprise value is 223.83 billion.
Market Cap | 205.21B |
Enterprise Value | 223.83B |
Important Dates
The next estimated earnings date is Tuesday, October 29, 2024.
Earnings Date | Oct 29, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Novartis AG has 2.02 billion shares outstanding. The number of shares has decreased by -3.53% in one year.
Shares Outstanding | 2.02B |
Shares Change (YoY) | -3.53% |
Shares Change (QoQ) | -0.49% |
Owned by Insiders (%) | 0.10% |
Owned by Institutions (%) | 38.41% |
Float | 1.93B |
Valuation Ratios
The trailing PE ratio is 23.09 and the forward PE ratio is 15.14. Novartis AG's PEG ratio is 1.69.
PE Ratio | 23.09 |
Forward PE | 15.14 |
PS Ratio | 4.73 |
PB Ratio | 5.47 |
P/FCF Ratio | 16.42 |
PEG Ratio | 1.69 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.77, with an EV/FCF ratio of 17.91.
EV / Earnings | 15.40 |
EV / Sales | 5.10 |
EV / EBITDA | 12.77 |
EV / EBIT | 16.90 |
EV / FCF | 17.91 |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 69.18.
Current Ratio | 0.93 |
Quick Ratio | 0.61 |
Debt / Equity | 69.18 |
Debt / EBITDA | 1.48 |
Debt / FCF | 2.08 |
Interest Coverage | 16.31 |
Financial Efficiency
Return on equity (ROE) is 21.50% and return on invested capital (ROIC) is 12.22%.
Return on Equity (ROE) | 21.50% |
Return on Assets (ROA) | 8.86% |
Return on Capital (ROIC) | 12.22% |
Revenue Per Employee | 577,272 |
Profits Per Employee | 191,105 |
Employee Count | 76,057 |
Asset Turnover | 0.47 |
Inventory Turnover | 1.71 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.22% in the last 52 weeks. The beta is 0.50, so Novartis AG's price volatility has been lower than the market average.
Beta (5Y) | 0.50 |
52-Week Price Change | +13.22% |
50-Day Moving Average | 98.08 |
200-Day Moving Average | 91.41 |
Relative Strength Index (RSI) | 56.69 |
Average Volume (20 Days) | 2,341,191 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of CHF 43.91 billion and earned 14.53 billion in profits. Earnings per share was 7.04.
Revenue | 43.91B |
Gross Profit | 33.17B |
Operating Income | 13.28B |
Pretax Income | 9.79B |
Net Income | 14.53B |
EBITDA | 17.34B |
EBIT | 13.28B |
Earnings Per Share (EPS) | 7.04 |
Balance Sheet
The company has 7.58 billion in cash and 26.05 billion in debt, giving a net cash position of -18.47 billion or -9.12 per share.
Cash & Cash Equivalents | 7.58B |
Total Debt | 26.05B |
Net Cash | -18.47B |
Net Cash Per Share | -9.12 |
Equity (Book Value) | 37.65B |
Book Value Per Share | 18.52 |
Working Capital | -1.72B |
Cash Flow
In the last 12 months, operating cash flow was 13.54 billion and capital expenditures -1.04 billion, giving a free cash flow of 12.50 billion.
Operating Cash Flow | 13.54B |
Capital Expenditures | -1.04B |
Free Cash Flow | 12.50B |
FCF Per Share | 6.17 |
Margins
Gross margin is 75.55%, with operating and profit margins of 30.25% and 33.10%.
Gross Margin | 75.55% |
Operating Margin | 30.25% |
Pretax Margin | 22.31% |
Profit Margin | 33.10% |
EBITDA Margin | 39.49% |
EBIT Margin | 30.25% |
FCF Margin | 28.47% |
Dividends & Yields
This stock pays an annual dividend of 3.30, which amounts to a dividend yield of 3.26%.
Dividend Per Share | 3.30 |
Dividend Yield | 3.26% |
Dividend Growth (YoY) | 153.13% |
Years of Dividend Growth | 3 |
Payout Ratio | 47.13% |
Buyback Yield | 3.53% |
Shareholder Yield | 6.79% |
Earnings Yield | 6.95% |
FCF Yield | 6.09% |
Stock Splits
The last stock split was on May 7, 2001. It was a forward split with a ratio of 40.
Last Split Date | May 7, 2001 |
Split Type | Forward |
Split Ratio | 40 |